for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

EU regulator evaluates Taw Pharma's dexamethasone as potential COVID-19 treatment

Sept 2 (Reuters) - Europe's healthcare regulator said on Wednesday it was evaluating Dexamethasone Taw as a potential COVID-19 treatment for hospitalised adult patients after it received an application from drug developer Taw Pharma. (bit.ly/31SOe1L) (Reporting by Pushkala Aripaka in Bengaluru; Editing by Shinjini Ganguli)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up